Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ANI Pharmaceuticals Inc (NASDAQ:ANIP)

46.67
Delayed Data
As of May 05
 +2.99 / +6.85%
Today’s Change
26.80
Today|||52-Week Range
73.54
+3.42%
Year-to-Date

Today’s Trading

Previous close43.68
Today’s open44.98
Day’s range42.37 - 47.57
Volume440,404
Average volume (3 months)228,652
Market cap$528.2M
Dividend yield--
Data as of 05/05/2016

Growth & Valuation

Earnings growth (last year)-49.03%
Earnings growth (this year)+22.98%
Earnings growth (next 5 years)+14.70%
Revenue growth (last year)+36.36%
P/E ratio35.4
Price/Sales6.83
Price/Book3.32

Competitors

 Today’s
change
Today’s
% change
RTRXRetrophin Inc-0.10-0.67%
ATRAAtara Biotherapeutic...-0.73-4.56%
AVXSAveXis Inc-0.40-1.75%
FMIFoundation Medicine ...+0.08+0.48%
Data as of 4:00pm ET, 05/05/2016

Financials

Next reporting dateAugust 1, 2016
EPS forecast (this quarter)$0.75
Annual revenue (last year)$76.3M
Annual profit (last year)$15.3M
Net profit margin20.03%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur S. Przybyl
Vice President-
Operations
James G. Marken
Corporate headquarters
Baudette, Minnesota

Forecasts

Partner Offers

Search for Jobs